|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Armata Pharmaceuticals, Inc (ARMP) |
|
|
$0.32 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
24,940,000 |
| Market
Cap: |
7.93(M) |
| Last
Volume: |
4,742 |
Avg
Vol: |
4,729 |
| 52
Week Range: |
$0.3179 - $0.3179 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Co. is developing and advancing its primary clinical phage candidate for Pseudomonas aeruginosa. Co. is also developing a phage product candidate for Staphylococcus aureus for the treatment of S. aureus bacteremia. In addition, Co. has phage development efforts underway to target other indications including non-cystic fibrosis bronchiectasis, prosthetic joint infections and hospitalized pneumonia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2007-06-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,624,097 |
|
- |
|
| Poston David J |
CFO & VP Finance |
• – – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
36,700 |
|
- |
|
| Perry Michael S |
Director |
– • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Parker H Stewart |
President & CEO |
• • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
81,175 |
|
- |
|
| Levy Nelson L |
Director |
– • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,070 |
|
- |
|
| Hawley Roger |
Director |
– • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Davie Joseph Md Phd |
Director |
– • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
11,000 |
|
- |
|
| Cook Jeremy Curnock |
Chairman of the Board |
• • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Carter Barrie J Phd |
Executive Vice President |
• – – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
48,766 |
|
- |
|
| Bowman Jack L |
Director |
– • – |
2007-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,500 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2006-11-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000,000 |
2,170,410 |
|
- |
|
| Parker H Stewart |
President & CEO |
• • – |
2006-09-05 |
4 |
B |
$1.91 |
$19,928 |
D/D |
10,000 |
31,175 |
2.81 |
- |
|
| Poston David J |
Acting CFOOfficer |
• – – |
2005-10-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,000 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-15 |
4 |
S |
$0.70 |
$3,345 |
I/I |
(4,700) |
11,704,095 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-12 |
4 |
S |
$0.71 |
$6,698 |
I/I |
(9,500) |
11,708,795 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-10 |
4 |
S |
$0.73 |
$18,263 |
I/I |
(25,000) |
11,718,295 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-09 |
4 |
S |
$0.75 |
$9,225 |
I/I |
(12,200) |
11,743,295 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-08 |
4 |
S |
$0.76 |
$10,100 |
I/I |
(13,253) |
11,755,495 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-05 |
4 |
S |
$0.76 |
$19,100 |
I/I |
(25,000) |
11,768,748 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-04 |
4 |
S |
$0.76 |
$9,575 |
I/I |
(12,500) |
11,793,748 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-03 |
4 |
S |
$0.76 |
$6,888 |
I/I |
(9,000) |
11,806,248 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-02 |
4 |
S |
$0.77 |
$13,323 |
I/I |
(17,200) |
11,815,248 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-08-01 |
4 |
S |
$0.77 |
$19,391 |
I/I |
(25,000) |
11,832,448 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-07-29 |
4 |
S |
$0.80 |
$6,400 |
I/I |
(8,000) |
11,857,448 |
|
- |
|
| Biogen Idec Ma Inc |
10% Owner |
– – • |
2005-07-28 |
4 |
S |
$0.80 |
$12,000 |
I/I |
(15,000) |
11,865,448 |
|
- |
|
129 Records found
|
|
Page 4 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
